TRINITY BIOTECH INVT LTD's ticker is and the CUSIP is 89643QAB4. A total of 1 filers reported holding TRINITY BIOTECH INVT LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $8,947,000 | +1.4% | 12,015,000 | 0.0% | 0.12% | -10.4% |
Q2 2019 | $8,822,000 | -4.9% | 12,015,000 | 0.0% | 0.14% | -36.3% |
Q1 2019 | $9,272,000 | -0.7% | 12,015,000 | 0.0% | 0.21% | -18.8% |
Q4 2018 | $9,335,000 | +0.3% | 12,015,000 | 0.0% | 0.26% | -7.8% |
Q3 2018 | $9,303,000 | -5.9% | 12,015,000 | 0.0% | 0.28% | -7.2% |
Q2 2018 | $9,891,000 | +1.9% | 12,015,000 | 0.0% | 0.30% | +32.6% |
Q1 2018 | $9,709,000 | +9.8% | 12,015,000 | +8.8% | 0.23% | -11.9% |
Q4 2017 | $8,843,000 | -0.5% | 11,040,000 | 0.0% | 0.26% | -17.1% |
Q3 2017 | $8,890,000 | -1.3% | 11,040,000 | 0.0% | 0.32% | -17.1% |
Q2 2017 | $9,010,000 | +28.1% | 11,040,000 | +28.5% | 0.38% | +45.6% |
Q1 2017 | $7,034,000 | -3.9% | 8,590,000 | 0.0% | 0.26% | -8.7% |
Q4 2016 | $7,321,000 | – | 8,590,000 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |